Immunoglobulin M–enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation

R Rieben, A Roos, Y Muizert, C Tinguely… - Blood, The Journal …, 1999 - ashpublications.org
An important antiinflammatory mechanism of intravenous immunoglobulin preparations (IVIG)
is their ability to block complement activation. The purpose of this study was to compare …

[HTML][HTML] Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016

…, N Widmer, M Hotz, C Tinguely… - …, 2018 - eurosurveillance.org
Background and aim Hepatitis E virus (HEV) is a virus of emerging importance to transfusion
medicine. Studies from several European countries, including Switzerland, have reported …

Quantitation and characterization of anti‐Galα1–3Gal antibodies in sera of 200 healthy persons

R Buonomano, C Tinguely, R Rieben… - …, 1999 - Wiley Online Library
Buonomano R, Tinguely C, Rieben R, Mohacsi PJ, Nydegger UE. Quantitation and characterization
of anti‐Galα1–3Gal antibodies in sera of 200 healthy persons. Xenotransplantation …

[HTML][HTML] Multicentre performance evaluation of the Elecsys Anti-SARS-CoV-2 immunoassay as an aid in determining previous exposure to SARS-CoV-2

…, M Majchrzak, A Muehlbacher, C Tinguely… - Infectious Diseases and …, 2021 - Springer
Introduction We performed a multicentre evaluation of the Elecsys ® Anti-SARS-CoV-2
immunoassay (Roche Diagnostics), an assay utilising a recombinant protein representing the …

[HTML][HTML] Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum

C Niederhauser, C Tinguely, M Stolz, M Vock… - Viruses, 2022 - mdpi.com
During the last few decades, efforts to increase the safety of blood and blood products have
mainly focused on preventing the viral infections HCV, HIV, HBV and Treponema pallidum. …

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion‐transmitted hepatitis B virus infection in Switzerland, a low‐endemic region

M Stolz, C Tinguely, M Graziani, S Fontana… - …, 2010 - Wiley Online Library
BACKGROUND: The risk of transfusion‐transmitted hepatitis B virus (HBV) in Switzerland
by testing blood donors for hepatitis B surface antigen (HBsAg) alone has been historically …

H epatitis B virus DNA viral load determination in hepatitis B surface antigen–negative S wiss blood donors

M Stolz, C Tinguely, S Fontana, C Niederhauser - Transfusion, 2014 - Wiley Online Library
Background Nucleic acid test ( NAT ) hepatitis B virus ( HBV ) screening for all blood donations
with a sensitivity limit of 25 IU / mL in the individual donation is mandatory in S witzerland …

Selective testing of at-risk blood donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland

C Niederhauser, J Gottschalk, C Tinguely - Transfusion Medicine and …, 2016 - karger.com
Background: Population migrations and overseas recreational travel to regions at risk for
tropical diseases are increasing. A major challenge in non-endemic countries is to decrease …

Low-frequency blood group antigens in Switzerland

…, E Rigal, JD Tissot, C Tinguely… - Transfusion Medicine …, 2018 - karger.com
Background: High-frequency blood group antigens (HFA) are present in >90% of the human
population, according to some reports even in >99% of individuals. Therefore, patients …

Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort

…, MR Blum, R Baldan, C Tinguely… - Immunity …, 2022 - Wiley Online Library
Introduction To assess the risk for COVID‐19 of police officers, we are studying the
seroprevalence in a cohort. The baseline cross‐sectional investigation was performed before a …